bioRN News

aimed analytics is a cutting-edge SaaS company providing AI-driven biomedical data analysis. Its platform enables fully automated, scalable, and reproducible analysis of complex omics data—without programming skills. Researchers simply upload data and ask questions in natural language. With rapid, cost-efficient workflows, aimed analytics helps biotech, pharma, and academia accelerate discovery and reduce dependency on scarce […]

dPTx is building a next-generation platform that transforms protein R&D through automation and structured data. By integrating robotic wet-lab workflows with a propriety smart ELN, they generate ML-ready datasets by design—enabling reproducibility, faster iteration, and scalable discovery. Unlike traditional CROs, they offer more than just services: dPTx provides a datapowered engine for protein production and […]

BASF creates chemistry for a sustainable future, combining economic success with environmental protection and social responsibility. With about 112,000 employees worldwide, BASF supports customers across nearly all sectors. In pharmaceuticals, BASF delivers high-quality excipients and active ingredients, supporting effective, reliable formulations. With deep expertise in drug manufacturing and delivery, BASF offers solutions for Biopharma, Parenteral, […]

aimed analytics GmbH has successfully closed its first funding round, raising a six-digit investment. At the same time, the company has completed the acquisition of ValueData GmbH, further strengthening its position as a pioneer in AI-driven biomedical data analytics. “Our mission is clear: to shape the future of medicine through the power of data analytics. […]

Alumnus Bastian Linder discusses the origin of this start-up and how a tRNA mechanism is helping scientists understand the importance and use of various RNA modifications as they pertain to disease. With just two dots above a letter, the German umlaut can instantly change a word’s pronunciation, its quantity (singular to plural), or even its […]

Chordomas are rare bone tumors for which there are currently no effective drugs. A research team from the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg has now developed a promising approach: Tailor-made mini-proteins specifically block the central driver of tumor development. In the result, they slowed the growth […]

Key Milestone for PL BioScience as new headquarters are announced PL BioScience announced the next major step in its expansion – an upcoming move to a new 1,200 m² facility in Aachen, in September 2025. This key milestone will support the company’s growth and upscaling efforts, and provide the world’s largest HPL output, with 20,000L […]

A team of scientists from the German Cancer Research Center (DKFZ) and the Netherlands Cancer Institute has discovered a previously unknown vulnerability in cancer cells: When cell division is blocked with chemotherapeutic agents such as Taxol, cancer cells produce small immunogenic peptides that could open up new avenues for immune-based cancer therapies. Frequent cell division […]

Researchers identify neurotoxic protein complex – Pharmacological inhibitor opens up new perspectives for the development of effective therapies A molecular mechanism that significantly contributes to the progression of Alzheimer’s disease has been discovered by a research team led by neurobiologist Prof. Dr Hilmar Bading of Heidelberg University. In joint experiments with researchers from Shandong University […]